KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Supernus Pharmaceuticals (SUPN) Depreciation & Amortization (CF) (2016 - 2026)

Supernus Pharmaceuticals has reported Depreciation & Amortization (CF) over the past 15 years, most recently at $25.0 million for Q4 2025.

  • Quarterly Depreciation & Amortization (CF) rose 32.75% to $25.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $91.6 million through Dec 2025, up 13.86% year-over-year, with the annual reading at $91.6 million for FY2025, 13.86% up from the prior year.
  • Depreciation & Amortization (CF) was $25.0 million for Q4 2025 at Supernus Pharmaceuticals, up from $24.8 million in the prior quarter.
  • Over five years, Depreciation & Amortization (CF) peaked at $25.0 million in Q4 2025 and troughed at $6.6 million in Q1 2021.
  • The 5-year median for Depreciation & Amortization (CF) is $20.7 million (2023), against an average of $18.7 million.
  • The largest YoY upside for Depreciation & Amortization (CF) was 280.6% in 2021 against a maximum downside of 14.89% in 2021.
  • A 5-year view of Depreciation & Amortization (CF) shows it stood at $12.7 million in 2021, then soared by 64.07% to $20.8 million in 2022, then grew by 3.97% to $21.7 million in 2023, then dropped by 13.06% to $18.8 million in 2024, then soared by 32.75% to $25.0 million in 2025.
  • Per Business Quant, the three most recent readings for SUPN's Depreciation & Amortization (CF) are $25.0 million (Q4 2025), $24.8 million (Q3 2025), and $21.4 million (Q2 2025).